Association of preoperative antiviral treatment with incidences of post-hepatectomy liver failure in hepatitis B virus-related hepatocellular carcinoma

Table 5 Evaluation of the incremental value of hepatitis B virus DNA level in predicting post-hepatectomy liver failure

Model	AUC (95%CI)	ΔAUC	P value	Categorical NRI (95%CI)	P value	IDI (95%CI)	P value
ALBI + HBV DNA	0.709 (0.684-0.734)	0.037	0.011	0.940 (0.886-0.994)	< 0.0001	0.082 (0.080-0.084)	< 0.0001
FIB4 + HBV DNA	0.729 (0.705-0.754)	0.054	0.001	1.382 (1.341-1.423)	< 0.0001	0.112 (0.110-0.114)	< 0.0001
APRI + HBV DNA	0.725 (0.701-0.749)	0.030	0.003	1.374 (1.330-1.416)	< 0.0001	0.095 (0.094-0.097)	< 0.0001

ALBI: Albumin-bilirubin score; FIB-4: Fibrosis-4 score; APRI: Aspartate aminotransferase-to-platelet ratio index; HBV: Hepatitis B virus; AUC: Area under the curve; ΔAUC: The change in the area under the receiver operating characteristic curve; IDI: Integrated discrimination improvement; NRI: Net reclassification improvement.